The board shall place a drug in Schedule IV if it finds that:
(1) the drug has a low potential for abuse relative to drugs in Schedule III;
(2) the drug has currently accepted medical use in treatment in the United States; and
(3) abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in Schedule III.